Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment

Area of Science:

• Environmental toxicology
• Pharmacokinetics
• Chemical risk assessment

Background:

• High-throughput in vitro toxicity screening (HTS) efficiently identifies chemical bioactivity but may misrepresent in vivo effects due to pharmacokinetic differences.
• Reliance on nominal concentrations in HTS assays can lead to inaccurate predictions of chemical behavior in living organisms.

Purpose of the Study:

• To review the application of quantitative in vitro-to-in vivo extrapolation (QIVIVE) methods in high-throughput screening.
• To highlight the potential of QIVIVE in refining chemical testing priorities and high-throughput risk assessment.

Main Methods:

• Development of high-throughput in vitro hepatic clearance and protein binding assays.
• Refinement of quantitative in vitro-to-in vivo extrapolation (QIVIVE) methods.
• Utilizing reverse dosimetry to integrate chemical steady-state behavior with HTS data.

Main Results:

• QIVIVE methods enable prediction of xenobiotic steady-state pharmacokinetics.
• Reverse dosimetry determines external in vivo oral exposure (oral equivalents) needed to match in vitro bioactivity concentrations.
• Oral equivalents can be compared to human exposure estimates for risk assessment.

Conclusions:

• QIVIVE is a valuable tool for bridging in vitro and in vivo data in a high-throughput setting.
• This approach enhances the accuracy of chemical risk assessment and informs chemical testing strategies.
• QIVIVE holds promise for developing more effective high-throughput risk assessment strategies.